People · Operator
Named in public records as an officer, director or promoter · active 2009–2023 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Mobilion Systems, Inc. | — | Biotechnology | Series C | $105.1M | $1.7B | 2019 |
| Stratos Genomics Inc. | — | Biotechnology | Series B | $58.9M | $800.0M | 2010 |
| Singulex Inc | — | Biotechnology | Series B | $44.7M | $483.8M | 2011 |
| Stagezero Life Sciences Ltd. | — | Biotechnology | Series A | $27.1M | $23.9M | 2009 |
| Mainz Biomed N.V. | — | Biotechnology | Series A | $14.9M | $122.3M | 2023 |
| AdvanDx, Inc. | — | Biotechnology | Series A | $13.7M | $90.4M | 2015 |
Heiner Dreismann at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Heiner Dreismann on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Stephen Rose | 2 | 3 |
| Carl Gordon | 1 | 24 |
| Jason Smith | 1 | 14 |
| Gregory Johnson | 1 | 8 |
| CARL L. GORDON | 1 | 7 |
| Lee Huntsman | 1 | 5 |
| Todd Sone | 1 | 4 |
| Rory Riggs | 1 | 4 |
| Hironori Hozoji | 1 | 4 |
| Gregory R. Johnson | 1 | 3 |
| Dennis H. Langer | 1 | 3 |
| David Sable | 1 | 3 |
| Christopher D Earl | 1 | 3 |
| Garth MacRae | 1 | 2 |
| David M Rubin | 1 | 2 |
| Thomas P. Kelly | 1 | 2 |
| Craig Carra | 1 | 2 |
| Harold Kawaguchi | 1 | 2 |
| Leslie Auld | 1 | 2 |
| Karl Wassmann | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.